Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
CYTK on Nasdaq
Robert I. Blum - trading volume in the past year for Cytokinetics Inc
Holdings reported by Robert I. Blum for Cytokinetics Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
415K |
$21.4M |
$51.51 |
Dec 3, 2024 |
Direct |
|
|
| Common Stock |
2.08K |
$107K |
$51.51 |
Dec 3, 2024 |
by Trust 1 |
|
|
| Common Stock |
2.08K |
$107K |
$51.51 |
Dec 3, 2024 |
by Trust 2 |
|
|
| Non-Qualified Stock Option (Right to Buy) |
113K |
|
|
Jul 10, 2024 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (Right to Buy) |
54.7K |
|
|
Dec 2, 2024 |
Direct |
Common Stock |
|
| Incentive Stock Option (Right to Buy) |
1.57K |
|
|
Mar 14, 2024 |
Direct |
Common Stock |
|
Transactions reported by Robert I. Blum for Cytokinetics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.